These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23370378)

  • 1. Dendritic cell vaccination in autoimmune disease.
    Gross CC; Wiendl H
    Curr Opin Rheumatol; 2013 Mar; 25(2):268-74. PubMed ID: 23370378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerogenic dendritic cells for reprogramming of lymphocyte responses in autoimmune diseases.
    García-González P; Ubilla-Olguín G; Catalán D; Schinnerling K; Aguillón JC
    Autoimmun Rev; 2016 Nov; 15(11):1071-1080. PubMed ID: 27485011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality?
    Van Brussel I; Lee WP; Rombouts M; Nuyts AH; Heylen M; De Winter BY; Cools N; Schrijvers DM
    Autoimmun Rev; 2014 Feb; 13(2):138-50. PubMed ID: 24120737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does our current understanding of the molecular basis of immune tolerance predict new therapies for autoimmune disease?
    Tarner IH; Fathman CG
    Nat Clin Pract Rheumatol; 2006 Sep; 2(9):491-9. PubMed ID: 16951704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis.
    Schinnerling K; Soto L; García-González P; Catalán D; Aguillón JC
    Autoimmun Rev; 2015 Jun; 14(6):517-27. PubMed ID: 25633325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral tolerance: elucidation of mechanisms and application to treatment of autoimmune diseases.
    Fowler E; Weiner HL
    Biopolymers; 1997; 43(4):323-35. PubMed ID: 9316395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of tolerogenic dendritic cells towards heat-shock proteins: a novel therapeutic strategy for autoimmune diseases?
    Jansen MAA; Spiering R; Broere F; van Laar JM; Isaacs JD; van Eden W; Hilkens CMU
    Immunology; 2018 Jan; 153(1):51-59. PubMed ID: 28804903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation, Characteristics and Clinical Trials of Ex Vivo Generated Tolerogenic Dendritic Cells.
    Kim SH; Jung HH; Lee CK
    Yonsei Med J; 2018 Sep; 59(7):807-815. PubMed ID: 30091313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerogenic dendritic cells for autoimmune disease and transplantation.
    Thomson AW; Robbins PD
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii90-6. PubMed ID: 19022823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrathymic generation of regulatory T cells--chances and challenges for prevention of autoimmune disease.
    Daniel C; von Boehmer H
    Adv Immunol; 2011; 112():177-213. PubMed ID: 22118409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.
    Weiner HL; Friedman A; Miller A; Khoury SJ; al-Sabbagh A; Santos L; Sayegh M; Nussenblatt RB; Trentham DE; Hafler DA
    Annu Rev Immunol; 1994; 12():809-37. PubMed ID: 8011298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells as targets or therapeutics in rheumatic autoimmune disease.
    Thomas R
    Curr Opin Rheumatol; 2014 Mar; 26(2):211-8. PubMed ID: 24389864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific tolerogenic dendritic cells ameliorate the severity of murine collagen-induced arthritis.
    Ning B; Wei J; Zhang A; Gong W; Fu J; Jia T; Yang SY
    PLoS One; 2015; 10(6):e0131152. PubMed ID: 26107250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of tolerogenic dendritic cells by NF-κB blockade and Fcγ receptor modulation.
    Carreño LJ; Riedel CA; Kalergis AM
    Methods Mol Biol; 2011; 677():339-53. PubMed ID: 20941620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerogenic dendritic cells: the ins and outs of outcome.
    Xiao BG; Huang YM; Link H
    J Immunother; 2006; 29(5):465-71. PubMed ID: 16971802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis.
    Yang S; Li W; Liu W; Gao C; Zhou B; Li S; Li Y; Kong Y
    Clin Immunol; 2006 Oct; 121(1):63-73. PubMed ID: 16904381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications.
    Rutella S; Lemoli RM
    Immunol Lett; 2004 Jun; 94(1-2):11-26. PubMed ID: 15234530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases.
    Mackern-Oberti JP; Llanos C; Vega F; Salazar-Onfray F; Riedel CA; Bueno SM; Kalergis AM
    Autoimmun Rev; 2015 Feb; 14(2):127-39. PubMed ID: 25449681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral tolerance: therapeutic implications for autoimmune diseases.
    Faria AM; Weiner HL
    Clin Dev Immunol; 2006; 13(2-4):143-57. PubMed ID: 17162357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral tolerance in the control of experimental models of autoimmune disease.
    Staines NA; Harper N
    Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.